Lonza defies widening spreads to price close to fair value
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings
Corporate BondsHigh grade and crossover bonds

Lonza defies widening spreads to price close to fair value

Sophie Astles
November 06, 2023 06:42 PM
FILE - This July 22, 2015 file picture shows a factory of Swiss company Lonza Group AG, in Visp, Switzerland. Pharmaceutical supplier Lonza of Switzerland says it is buying InterHealth Nutraceuticals, Inc., a California-based company that makes ingredient

Strong name recognition helps Swiss pharma company achieve size at a tight price

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Swiss FrancsBNP ParibasUBSZKBCommerzbankHigh grade and crossover bondsHealth and Biotech
SA
Sophie Astles
Awards Research Editor GlobalCapital
Gift this article